Evidence map›Paper›PMID 40852129›Full record

ArticleDiscover applied sciences2025

3D Multi-Tissue microphysiological system for Anti-Cancer and cardiotoxicity drug screening with automated image analysis.

Edgar A Borrego, Jose L Perez, Aibhlin Esparza, Paula Delgado, Kevin Moreno, Wilson Poon, David Chambers, Binata Joddar, Sylvia L Natividad-Diaz

Abstract read
In one paragraph

Article in Discover applied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Edgar A BorregoDepartment of Metallurgical, Materials, and Biomedical Engineering (MMBME), The University of Texas at El Paso (UTEP), 500 W University Ave, 79968 El Paso, TX, USA.
Jose L PerezDepartment of Metallurgical, Materials, and Biomedical Engineering (MMBME), The University of Texas at El Paso (UTEP), 500 W University Ave, 79968 El Paso, TX, USA.
Aibhlin EsparzaDepartment of Metallurgical, Materials, and Biomedical Engineering (MMBME), The University of Texas at El Paso (UTEP), 500 W University Ave, 79968 El Paso, TX, USA.
Paula DelgadoDepartment of Metallurgical, Materials, and Biomedical Engineering (MMBME), The University of Texas at El Paso (UTEP), 500 W University Ave, 79968 El Paso, TX, USA.
Kevin MorenoDepartment of Computer Science (CS), The University of Texas at El Paso (UTEP), 500 W University Ave, El Paso, 79968 El Paso, TX, USA.
Wilson PoonDepartment of Metallurgical, Materials, and Biomedical Engineering (MMBME), The University of Texas at El Paso (UTEP), 500 W University Ave, 79968 El Paso, TX, USA.
David ChambersSouthwest Research Institute, 6220 Culebra Road, San Antonio, TX 78238, USA.
Binata JoddarInspired Materials & Stem-Cell Based Tissue Engineering Laboratory (IMSTEL), School of Chemical, Biological, and Environmental Engineering, Oregon State University, 105 SW 26th St #116, Corvallis, OR 97331, USA.
Sylvia L Natividad-DiazDepartment of Metallurgical, Materials, and Biomedical Engineering (MMBME), The University of Texas at El Paso (UTEP), 500 W University Ave, 79968 El Paso, TX, USA.

Funding

UTEP Border Biomedical Research CenterU54MD007592 · NIMHD · UNIVERSITY OF TEXAS EL PASO · PI Michael J Kenney · 2019 to 2026
$35.1M
3D in vitro Human Stem Cell-derived Cardiovascular Tissue Model and Microfluidic Platform for Targeted Preclinical Drug ScreeningSC2GM144164 · NIGMS · UNIVERSITY OF TEXAS EL PASO · PI NATIVIDAD-DIAZ, SYLVIA · 2022 to 2024
$455k
NIGMS NIH HHS SC2 GM144164NIMHD NIH HHS U54 MD007592
6 · The paper itself

Abstract

In vitro 3D tissue models within microfluidic-based microphysiological systems (MPS) provide controlled and reproducible platforms for quantification of isolated cellular processes in response to biochemical or biophysical stimulus. This study demonstrates the development of a 3D MPS with a dual-chamber, closed-capillary circuit microfluidic culture platform to study chemotherapy drug efficacy in vitro for aggressive malignancies such as breast cancer and glioblastoma. This novel microfluidic system was used to model HER2 + breast cancer (BCTM-SKBR3) co-cultured with cardiac (CTM-AC16) tissue for proof-of-concept chemotherapy-induced cardiotoxicity studies. To further demonstrate the versatility of this system, a glioblastoma tissue model with chemotherapy efficacy studies was included. Additionally, implementation of a Python-based automated image analysis script (AIAPS) facilitated quantification of cell size within the tissue models from 3D fluorescence z-stack images. The results demonstrate maintenance of lineage-specific biomarker expression, physiologically relevant cell morphology and structural organization, and detectable changes in cell sizes with chemotherapy treatment within the 3D tissue models. These results demonstrated the system's potential for use as a preclinical drug screening platform.

Identifiers

PMID40852129
PMCPMC12368580

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.